Beyer S

No ORCID on file · 11 papers in corpus · active 2020-2026

Study types

  • other 3
  • review 2
  • article 1
  • preprint 1
  • rct 1

Condition tags

  • endometriosis 7
  • chronic_pelvic_pain 2
  • dysmenorrhea 1
  • infertility 1
  • dyspareunia 1
other 2026
Archives of gynecology and obstetrics ·doi:10.1007/s00404-026-08331-4

OBJECTIVE: The study aimed to evaluate the long-term outcomes of surgical management in patients with peritoneal endometriosis, focusing on postoperative pain trajectories, re-operation rates, fertility outcomes, and the potential influence…

other 2026
Geburtshilfe und Frauenheilkunde ·doi:10.1055/a-2663-4218

TARGET GROUP: Physicians interested in endometriosis and infertility as well as medical teams in reproductive medicine and endometriosis centers. OBJECTIVE: A practical guide for clinical decision-making. This guide was compiled by the wor…

other 2026
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-026-01559-4

BACKGROUND: Endometriosis is a highly prevalent, hormone-driven chronic disease characterized by the growth of endometrial tissue outside the uterine cavity. Despite its impact, the mechanisms underlying the disease’s pathogenesis remain po…

rct 2025
BMC women's health ·doi:10.1186/s12905-025-03736-w

BACKGROUND: The global increase in interest in endometriosis highlights the importance of further investigations concerning this so-called benign gynecological disease. Owing to their severe presentation of symptoms, patients suffer from an…

review 2024
MMW Fortschritte der Medizin ·doi:10.1007/s15006-024-3855-x
2024
Translational oncology ·doi:10.1016/j.tranon.2024.102116

ObjectivesThe chemokine CCL22 is recognized for recruiting immunosuppressive regulatory T-cells (Treg) that contribute to disease progression in various tumor entities helping them to evade the host immune response. Our study aims to identi…

2022
Scientific reports ·doi:10.1038/s41598-022-05785-9

In recurrent epithelial ovarian cancer (EOC) most patients develop platinum-resistance. On molecular level the NRF2 pathway, a cellular defense mechanism against reactive oxygen species, is induced. In this study, we investigate AKR1C1/2, t…

review 2022
MMW Fortschritte der Medizin ·doi:10.1007/s15006-022-2175-2
article 2022
Archives of gynecology and obstetrics ·doi:10.1007/s00404-022-06730-x

PURPOSE: Endometriosis is known to be an underestimated disease. Lately the awareness of the disease seems to have improved. Aim of this analysis is to provide an overview of the development of treatment of patients diagnosed with endometri…

preprint 2022
·doi:10.21203/rs.3.rs-1784980/v1

Abstract PurposeEndometriosis is known to be an underestimated disease. Lately the awareness of the disease seems to have improved. Aim of this analysis is to provide an overview of the development of treatment of patients diagnosed with e…

2020
Histochemistry and cell biology ·doi:10.1007/s00418-020-01873-x

Several risk factors like obesity and hyperlipidemia were described for endometrial cancer. Here, the nuclear NAD-dependent histone-deacetylase Sirtuin1 (SIRT1) seems to be important. SIRT1 is also involved in cell regulatory mechanisms and…